Cancer Cell

Published by: Cell Press  

People

  1. De Stanchina
    De Stanchina
  2. Levine
    Levine
  3. Rosen
    Rosen
  4. Sadelain
    Sadelain
  5. Socci
    Socci
  6. Viale
    Viale
  7. Abdel-Wahab
    Abdel-Wahab
  8. Carver
    Carver
  9. Chandarlapaty
    Chandarlapaty
  10. Ghossein
    Ghossein

Groups

  1. GSK Faculty (11)
  2. Department of Medicine (9)
  3. Center for Hematologic Malignancies (8)
  4. Hematologic Malignancies, Division of (7)
  5. Sloan Kettering Institute Faculty (7)
  6. Executive Committee, Center for Hematologic Malignancies (6)
  7. Sloan Kettering Institute Postdocs (6)
  8. Human Oncology and Pathogenesis Program (5)
  9. Molecular Pharmacology and Chemistry Program Faculty (5)
  10. Solid Tumor Oncology Division (4)
Search Within
  1. "2015"
Formats
  1. Journal Article (13)
Groups
  1. GSK Faculty (11)
  2. Department of Medicine (9)
  3. Center for Hematologic Malignancies (8)
  4. Hematologic Malignancies, Division of (7)
  5. Sloan Kettering Institute Faculty (7)
  6. Executive Committee, Center for Hematologic Malignancies (6)

More Groups

People
  1. Elisa De Stanchina (3)
  2. Neal Rosen (3)
  3. Ross Levine (3)
  4. Agnes Viale (2)
  5. Alan Shih (2)
  6. Franck Rapaport (2)

More People

Years
  1. 2015 (13)
Publishers
  1. Cell Press (13)

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Structural design of engineered costimulation determines tumor rejection kinetics and persistence of CAR T cells
    Journal Article

    Zhao, Z.; Condomines, M.; Van Der Stegen, S. J. C.; Perna, F.; Kloss, C. C.; Gunset, G.; Plotkin, J.; Sadelain, M.
    Cancer Cell (2015)

    Fulltext@MSK | Save
  • BRAF mutants evade ERK-dependent feedback by different mechanisms that determine their sensitivity to pharmacologic inhibition
    Journal Article

    Yao, Z.; Torres, N. M.; Tao, A.; Gao, Y.; Luo, L.; Li, Q.; de Stanchina, E.; Abdel-Wahab, O.; Solit, D. B.; Poulikakos, P. I.; more...
    Cancer Cell (2015)

    Fulltext@MSK | Save
  • DNA methylation and somatic mutations converge on the cell cycle and define similar evolutionary histories in brain tumors
    Journal Article

    Mazor, T.; Pankov, A.; Johnson, B. E.; Hong, C.; Hamilton, E. G.; Bell, R. J. A.; Smirnov, I. V.; Reis, G. F.; Phillips, J. J.; Barnes, M. J.; more...
    Cancer Cell (2015)

    Fulltext@MSK | Save
  • CHZ868, a type II JAK2 inhibitor, reverses type I JAK inhibitor persistence and demonstrates efficacy in myeloproliferative neoplasms
    Journal Article

    Meyer, S.; Keller, M.; Chiu, S.; Koppikar, P.; Guryanova, O.; Rapaport, F.; Xu, K.; Manova, K.; Pankov, D.; O'reilly, R.; more...
    Cancer Cell (2015)

    Fulltext@MSK | Save
  • Feedback suppression of PI3Kα signaling in PTEN-mutated tumors is relieved by selective inhibition of PI3Kβ
    Journal Article

    Schwartz, S.; Wongvipat, J.; Trigwell, C. B.; Hancox, U.; Carver, B. S.; Rodrik-Outmezguine, V. ; Will, M.; Yellen, P.; de Stanchina, E.; Baselga, J.; more...
    Cancer Cell (2015)

    Fulltext@MSK | Save
  • SRSF2 mutations contribute to myelodysplasia by mutant-specific effects on exon recognition
    Journal Article

    Kim, E.; Ilagan, J. O.; Liang, Y.; Daubner, G. M.; Lee, S. C. W.; Ramakrishnan, A.; Li, Y.; Chung, Y. R.; Micol, J. B.; Murphy, M. E.; more...
    Cancer Cell (2015)

    Fulltext@MSK | Save
  • Designed to kill: Novel menin-MLL inhibitors target MLL-rearranged leukemia
    Journal Article

    Kühn, M. W. M.; Armstrong, S. A.
    Cancer Cell (2015)

    Fulltext@MSK | Save
  • The journey from discoveries in fundamental immunology to cancer immunotherapy
    Journal Article

    Miller, J. F. A. P.; Sadelain, M.
    Cancer Cell (2015)

    Fulltext@MSK | Save
  • Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemia
    Journal Article

    Shih, A. H.; Jiang, Y.; Meydan, C.; Shank, K.; Pandey, S.; Barreyro, L.; Antony-Debre, I.; Viale, A.; Socci, N.; Sun, Y.; more...
    Cancer Cell (2015)

    Fulltext@MSK | Save
  • AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas
    Journal Article

    Elkabets, M.; Pazarentzos, E.; Juric, D.; Sheng, Q.; Pelossof, R. A.; Brook, S.; Benzaken, A. O.; Rodon, J.; Morse, N.; Yan, J. J.; more...
    Cancer Cell (2015)

    Fulltext@MSK | Save

    • Cancer Cell – authorized name for:

    Name ISSN / ISBN Publisher
    Cancer Cell 1535-6108 Cell Press
    Cancer Cell 1535-6108 Cell Press
    Cancer Cell 15356108 Cell Press
    Cancer cell 18783686 Unknown
    Cancer Cell 18783686 Elsevier Inc.
    Cancer Cell 15356108 Elsevier Inc.
    Cancer Cell 1535-6108 Elsevier Inc.
    Cancer Cell 15356108 2019
    Cancer Cell 15356108 Unknown
    Cancer Cell 1535-6108 Unknown
    Cancer Cell 15356108 Francis Crick Institute
    Cancer Cell 1535-6108 Cell Press
    Cancer Cell 1535-6108 Cell Press
    Cancer Cell 15356108 Elsevier Inc.
    Cancer Cell 1535-6108 Cell Press
    Cancer Cell 18783686 Elsevier Inc.
    Cancer Cell 15356108 2024
    Cancer Cell 15356108 2017
    Cancer Cell 15356108 The Author(s)
    Cancer Cell 15356108 2023
    Cancer Cell 15356108 The Authors